Total planned funding: $850,454,478
Clear active filters
HTXD: Treatment: ARV Drugs
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Kenya | $177,404,295 |
Nigeria | $139,321,553 |
Tanzania | $118,210,385 |
Uganda | $105,433,516 |
Zambia | $78,327,981 |
Mozambique | $41,844,018 |
South Africa | $29,490,557 |
Côte d'Ivoire | $28,110,015 |
Rwanda | $27,802,458 |
Zimbabwe | $27,596,822 |
Haiti | $17,410,002 |
Vietnam | $14,258,275 |
Democratic Republic of the Congo | $10,745,355 |
Ukraine | $8,800,000 |
Botswana | $7,486,042 |
Ethiopia | $7,000,000 |
Eswatini | $6,428,711 |
Namibia | $1,879,596 |
South Sudan | $1,829,817 |
Guyana | $772,197 |
Malawi | $150,069 |
Cameroon | $69,354 |
Papua New Guinea | $57,440 |
Central Asia Region | $26,020 |
Organizational Types
Private Contractor | $636,850,268 |
Host Country Government Agency | $100,748,347 |
Unknown | $49,705,836 |
NGO | $24,713,998 |
FBO | $16,091,491 |
Implementing Agency | $14,376,825 |
University | $4,684,263 |
Own Agency | $2,209,824 |
Parastatal | $1,073,626 |
Program Areas
Treatment | $850,454,478 |
Budget Codes
HTXD: Treatment: ARV Drugs | $850,454,478 |
Top Partner Programs
Chemonics International:
$442,737,995
View countries